<DOC>
	<DOCNO>NCT01640912</DOCNO>
	<brief_summary>The primary purpose study evaluate safety tolerability single intradermal administration RXI-109 small surgical incision abdominal skin later remove elective abdominoplasty . The effect RXI-109 versus placebo scar incision site evaluate visually histologically .</brief_summary>
	<brief_title>Evaluation Safety , Pharmacokinetics , Preliminary Effect Scar Formation RXI-109</brief_title>
	<detailed_description />
	<mesh_term>Cicatrix</mesh_term>
	<criteria>Subject must female general good health normal screen value Subject must good surgical candidate elective abdominoplasty Subjects must pregnant lactate utilize effective method contraception ( childbearing potential exists ) Currently pregnant lactate BMI great 35 screening Use tobacco nicotinecontaining product within month prior enrollment study Any medical condition current therapy would make subject unsuitable study opinion PI</criteria>
	<gender>Female</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>Scar</keyword>
	<keyword>Scar prevention</keyword>
	<keyword>Fibrosis</keyword>
</DOC>